SOURCE: Quanticate


March 05, 2014 08:30 ET

Quanticate Expands Global Operations for Biostatistics and Programming in Clinical Trials

Bangalore and North Carolina Facilities Look to Expand Staff After the Award of Two Large FSPs

BANGALORE, INDIA and RESEARCH TRIANGLE PARK, NC--(Marketwired - Mar 5, 2014) - Quanticate, a leading global data-focused clinical research organization (CRO) today announced the expansion of its global resources to support clinical trials. The region most affected is Bangalore and North Carolina, particularly in the areas of biostatistics and statistical programming, following the award of large functional service provision (FSP) contracts with two industry-leading pharmaceutical companies.

Quanticate is looking to significantly grow its resource capabilities and will be recruiting staff over a range of roles in biostatistics and statistical programming across all levels of seniority throughout 2014 based upon its overall pipeline of work. Opportunities will include graduate to principal roles in India and the US as well as other global locations.

"The expansion of our current customers coupled with the addition of new partnerships and two large-scale FSPs, has resulted in the need to expand our resource base across all our locations," explained Daniel Chapple, Chief Commercial Officer. "This expansion will also enable us to extend our presence to other cities in India and we are currently in the process of identifying facilities," continued Chapple.

The addition of two new partnerships means that Quanticate is now supporting biostatistics and programming for six of the Top 8 pharmaceutical companies and has gained extensive experience in successfully supporting companies in strategic partnerships within the data field. "Many companies are seeing the benefits from companies that can offer global expertise in their niche fields rather than using full service CROs whose primary focus is monitoring and project management," explains David Underwood, CEO of Quanticate. Underwood continues, "This approach can also drastically reduce operational oversight on the client side where successful partnerships are built on quality, performance, trust and understanding. It also means clients gain from the big benefit of having subject experts supporting their programs of work."

About Quanticate
Quanticate, headquartered in the UK and USA, is a leading global Clinical Research Organization (CRO) primarily focused on the management, analysis and reporting of data from clinical trials and post-marketing surveillance. Our team has a passion for excellence and provides high quality, efficient outsourcing solutions for companies who need additional capacity or who want to outsource certain activities in their entirety.

Clinical and post-marketing services include scalable on-site and off-site clinical data management, biostatistics, clinical programming, PK/PD analysis, medical writing, pharmacovigilance and statistical consultancy. Quanticate is the first CRO to introduce the Centralized Service Provision (CSP) approach to outsourcing supported by its data centralization and visualization tool for both single study and cross-study data analysis. Please visit the new website at for further information and access to white papers.

Contact Information

  • Media Contact:
    Valerie Harding
    Ripple Effect Communications
    Email Contact